Breast cancer

Updated 14 December 2016

Breast cancer outcomes vary according to race

According to a US study, African American women have a higher risk of dying from breast cancer, compared to white women.


Some of the differences in breast cancer outcomes between white and black women in the U.S. can be attributed to biology, suggests a new study.

Higher risk of dying

Compared to black women, non-Hispanic white women were more likely to be diagnosed when their breast cancer was at an early stage, the research showed. And black women had a higher risk of dying from their breast cancer, compared to white women.

The study team thinks these disparities are due to "a combination of biology and other factors that warrant further investigation to improve survival of all women," said Dr. Ophira Ginsburg, one of the study's authors from the Women's College Hospital in Toronto.

Read: Breast cancer: myths and facts

The researchers write in JAMA that women diagnosed with early invasive breast cancer – known as stage I – have generally good outlooks, but there are racial differences in a number of factors that affect how well they do.

For the new study, the researchers used a U.S. database to analyze nearly 450,000 invasive breast cancers diagnosed between 2004 and 2011.

Overall, about 51 percent of white non-Hispanic women in the sample were diagnosed with early-stage cancers, which are thought to have the best prognosis if properly treated. Only about 37 percent of black women were diagnosed with early cancer, making them less likely to have that good prognosis.

The researchers also found that about 6 percent of black women were predicted to die within seven years after their breast cancer diagnosis, compared to about 3 percent of white women.

More common among black women

Black women were also more likely to die from small tumours, compared to white women.

Differences still remained after the researchers excluded women with a more aggressive form of breast cancer known as triple-negative, which is known to be more common among black women.

After accounting for various factors that are known to affect breast cancer outcomes – including income – the differences in outcomes persisted, which suggests to the researchers that other biological reasons – such as the aggressiveness of the tumours, for example – were behind the disparities.

They don't believe a lack of screening among black women leads to a later diagnosis of cancer, because the relationship is even seen in age groups that don't normally receive mammograms.

Ginsburg said that other characteristics that could not be completely accounted for within the study may influence the results, such as access to care.

Read: The inspiring story of a breast cancer survivor

"We do know that breast cancers in African American women do tend to be more aggressive than breast cancer in white women," said Dr. Nancy Keating, a cancer researcher at Brigham and Women's Hospital in Boston who was not involved with the new study. "This – as well as other studies – supports this."

Era of precision medicine

However, it's still a question of how much of the differences between diagnosis and care can be attributed to biology, said Keating, who is also a professor of healthcare policy at Harvard Medical School.

Regardless of where the blame for more aggressive cancers lies, Dr. Funmi Olopade told Reuters Health that it's time women with breast cancer be treated as individuals.

"I think we're in an era of precision medicine now," said Olopade, who co-authored an editorial accompanying the new study. "What's really been rewarding about the advances in breast cancer research is that we're beginning to have the granular data to treat each patient as a unique individual and to look at their tumours as a unique tumour that we need to develop a strategy to treat."

Historically the U.S. focused on getting everyone screened," said Olopade, a breast cancer expert at the University of Chicago.

"The one size doesn't fit all," she said. "The conversation we should be having is 'we have breast cancer, but what type do I have?'"

SOURCES: and JAMA, online January 13, 2015.

Read more:

Diagnosed with breast cancer at 15
Risk factors for breast cancer
Focused approach to determine breast cancer risk

Image: Women with breast cancer ribbons from Shutterstock


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Breast cancer expert

Dr Gudgeon qualified in Birmingham, England, in 1968. She has more than 40 years experience in oncology, and in 1994 she founded her practice, Cape Breast Care, where she treats benign and malignant breast cancers. Dr Boeddinghaus obtained her qualification at UCT Medical School in 1994 and her MRCP in London in 1998. She has worked extensively in the field of oncology and has a special interest in the hormonal management of breast cancer. She now works with Dr Gudgeon at Cape Breast Care. Read more.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules